Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Mortality Trends Among Persons with Hemophilia in the United States, 2000-2021

Amanda B Payne, Binh Le, Meredith A Oakley, Brandi Dupervil, Marilyn J Manco-Johnson, Anjali Sharathkumar, Stacy E. Croteau, Rajiv K. Pruthi, Skye J Peltier, Norma Wolf, Roshni Kulkarni, Vanessa R Byams

Blood (2022) 140 (Supplement 1): 65–66.

https://doi.org/10.1182/blood-2022-163208

Published: 2022

Journal Articles

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Blood (2022) 140 (Supplement 1): 1899–1901.

https://doi.org/10.1182/blood-2022-158903

Published: 2022

Journal Articles

Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A

Huyen Tran, M. Elaine Eyster, Stacy E. Croteau, Margaret V. Ragni, Benjamin J. Samelson-Jones, Spencer Sullivan, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Magdalena Hofer, Charlie Li, Federico Mingozzi, Tiffany Chang, Gallia Levy

Blood (2022) 140 (Supplement 1): 10662–10664.

https://doi.org/10.1182/blood-2022-159027

Published: 2022

Journal Articles

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Matthew S. Evans, Witold B. Rybka, Stacy E. Croteau, Huyen Tran, John E.J. Rasko, Kristen Jaworski, Amy MacDougall, Savina Jaeger, Federico Mingozzi, Tiffany Chang, Gallia Levy

Blood (2022) 140 (Supplement 1): 10654–10655.

https://doi.org/10.1182/blood-2022-159017

Published: 2022

Journal Articles

Assessment of TRM-201 (Rofecoxib) Efficacy and Safety for Chronic Pain in Hemophilic Arthropathy: The Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy (RESET-HA), a Randomized, Double-Blind Placebo-Controlled Phase III Clinical Trial

Judith A. Boice, Tyler W. Buckner, Stacy E. Croteau, Nathaniel Katz, Robert F. Sidonio, Jr., Kim Mauer, James Bolognese, Mary Garfield, Mark Corrigon, Christopher E Walsh

Blood (2021) 138 (Supplement 1): 4243.

https://doi.org/10.1182/blood-2021-154056

Published: 2021

Journal Articles

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

Tariqa A Ackbarali, PhDc), Stacy E. Croteau, MD, Steven W. Pipe, MD, Kelly Tickle, MSN, APN, CWON, PCNS-BS, PPCNP-BC, Lori Long, Sonji Wilkes, BS, Kate Nammacher, MPH, Neil Frick, Katie Kowalski, Wendy Turell

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-141657

Published: 2020

Journal Articles

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Tyler W. Buckner, MDMSc, Shannon L Carpenter, MD, Stacy E. Croteau, MD, Adam Cuker, MDMS, Nabil Daoud, MA, Christine L Kempton, MDMSc, Lynn M Malec, MD, Thomas W. McLean, MD, Leslie J. Raffini, MD, Janice M Staber, MD, Michael Wang, MD, Crystal Watson, BS, Ayesha Zia, MD, Michael Recht, MD PhD

Blood (2020) 136 (Supplement 1): 2–3.

https://doi.org/10.1182/blood-2020-137696

Published: 2020

Journal Articles

Incidence of Pulmonary Embolus after Catheter Removal in Children with Central Venous Catheter Related Venous Thromboembolism: A Report from the CHAT Consortium

Julie Jaffray, MD, Lisa Baumann Kreuziger, MD MS, Brian Branchford, MD, Arash Mahajerin, Choo Phei A Wee, E Vince S Faustino, MD MHS, Zakai A Neil, MD, Stacy E. Croteau, MD, Michael Silvey, DO, John Fargo, DO, James D. Cooper, MD, Nihal Bakeer, MD, Amy Stillings, Emily Krava, Guy Young, MD, Neil A Goldenberg, MD PhD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-137216

Published: 2020

Journal Articles

First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α

Amy D Shapiro, MD, Barbara A. Konkle, MD, Stacy E. Croteau, MD, Wolfgang A. Miesbach, MD, Charles Richard Morris Hay, MDFRCP,FRCPath, Rashid Kazmi, MBBS, Marina Mihova, Savita Rangarajan, MD MBBS, John Pasi, MB, ChB, PhD FRCP, FRCPath, FRCPCH

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-141381

Published: 2020

Journal Articles

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Blood (2019) 134 (Supplement_1): 635.

https://doi.org/10.1182/blood-2019-126128

Published: 2019

Journal Articles

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Hanny Al-Samkari, MD, Stacy E. Croteau

Blood (2019) 134 (Supplement_1): 3395.

https://doi.org/10.1182/blood-2019-125364

Published: 2019

Journal Articles

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Lynn M Malec, MD, Stacy E. Croteau, Michael Callaghan, MD, Davide Matino, MD MSc, Kenneth Dale Friedman, MD, Robert F. Sidonio, Jr., MD MSc

Blood (2019) 134 (Supplement_1): 2407.

https://doi.org/10.1182/blood-2019-126196

Published: 2019

Journal Articles

Diagnostic and Therapeutic Decision Making in Pediatric Patients with Low Von Willebrand Factor

Michelle Shui, Loren D'Angelo, MSN, CPNP, Stacy E. Croteau

Blood (2019) 134 (Supplement_1): 2414.

https://doi.org/10.1182/blood-2019-123734

Published: 2019

Journal Articles

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Alfonso Iorio, Monika Maas Enriquez, Heinz Delesen, Alexander Solms, Stacy E. Croteau, Erik Berntorp

Blood (2019) 134 (Supplement_1): 3637.

https://doi.org/10.1182/blood-2019-127046

Published: 2019

Journal Articles

Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the Children's Hospital-Acquired Thrombosis (CHAT) Consortium

Julie Jaffray, MD, Arash Mahajerin, MD MS, Brian R. Branchford, MD, Anh Thy Nguyen, MSPH, Ernest Amankwah, PhD, Michael Silvey, DO, Stacy E. Croteau, James D. Cooper, MD, John H. Fargo, DO, Nihal Bakeer, MBBS, Amy Stillings, Emily Krava, E Vince S Faustino, MD MHS, Neil A. Zakai, MDMSc, Guy Young, MD, Neil A Goldenberg, MD PhD

Blood (2019) 134 (Supplement_1): 1150.

https://doi.org/10.1182/blood-2019-130788

Published: 2019

Journal Articles

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Lynn M. Malec, MD, Gilbert C. White, MD, Stacy E. Croteau, MD, Dunlei Cheng, PhD, Margaret V. Ragni, MD MPH

Blood (2018) 132 (Supplement 1): 2467.

https://doi.org/10.1182/blood-2018-99-115231

Published: 2018

Journal Articles

Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry

Brian R. Branchford, MD, Julie Jaffray, MD, Stacy E. Croteau, MD, Michael Silvey, DO, Nihal Bakeer, MBBS, James D. Cooper, MD, John H. Fargo, DO, Lingyun Ji, PhD, Richard Sposto, PhD, Jemily Malvar, Emily Krava, Amy Stillings, Neil A Goldenberg, MD PhD, Guy Young, Arash Mahajerin, MD MS

Blood (2018) 132 (Supplement 1): 142.

https://doi.org/10.1182/blood-2018-99-119968

Published: 2018

Journal Articles

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

Madhvi Rajpurkar, MD, Stacy E. Croteau, MD, Lisa N Boggio, MD MS, David L Cooper, MD

Blood (2018) 132 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2018-99-115153

Published: 2018

Journal Articles

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Blood (2018) 132 (Supplement 1): 487.

https://doi.org/10.1182/blood-2018-99-115495

Published: 2018

Journal Articles

Central Venous Catheters, a Major Culprit for Pediatric Venous Thrombosis: A Report from the Children's Hospital Acquired Thrombosis (CHAT) Project

Julie Jaffray, MD, Arash Mahajerin, MD MS, Stacy E. Croteau, MD, Michael Silvey, DO, Emily Krava, Amy Stillings, Guy Young, Brian R. Branchford, MD

Blood (2017) 130 (Supplement 1): 3706.

https://doi.org/10.1182/blood.V130.Suppl_1.3706.3706

Published: 2017

NARROW

Mortality Trends Among Persons with Hemophilia in the United States, 2000-2021

Long-Term Durable FVIII Expression with Improvements in Bleeding Rates Following AAV-Mediated FVIII Gene Transfer for Hemophilia A: Multiyear Follow-up on the Phase I/II Trial of SPK-8011

Rapid Clearance of Vector Following AAV-Mediated FVIII Gene Transfer in the Phase I/II Trial of SPK-8011 in People with Hemophilia A

The Effects of Immunomodulation with Corticosteroids to Manage an AAV Capsid Immune response in the Phase I/II Study of SPK-8011

Assessment of TRM-201 (Rofecoxib) Efficacy and Safety for Chronic Pain in Hemophilic Arthropathy: The Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy (RESET-HA), a Randomized, Double-Blind Placebo-Controlled Phase III Clinical Trial

Assessing Patient and Provider Perspectives, Clinical Practice, Behaviors, and Knowledge on Hemophilia A Care

Hemophilia Natural History Study (ATHN 7): Baseline Characteristics, Adverse Events, and Self-Reported Health Status of Individuals with Hemophilia a and B

Incidence of Pulmonary Embolus after Catheter Removal in Children with Central Venous Catheter Related Venous Thromboembolism: A Report from the CHAT Consortium

First-in-Human Phase 1/2 Clinical Trial of SIG-001, an Innovative Shielded Cell Therapy Platform, for Hemophilia Α

The Children's Hospital-Acquired Thrombosis (CHAT) Consortium Admission Risk-Assessment Models from Traditional Biostatistics and Machine Learning

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Spontaneous Bleeding and Poor Bleeding Response with Extended Half-Life Factor IX Products: A Survey of Select US and Canadian Hemophilia Treatment Centers

Diagnostic and Therapeutic Decision Making in Pediatric Patients with Low Von Willebrand Factor

Correlations between von Willebrand Factor Antigen Levels and Factor VIII Pharmacokinetics Are Similar across Different FVIII Products in Patients with Severe Hemophilia A

Assessing Venous Thromboembolism Risk in Critically Ill Children: A Report from the Children's Hospital-Acquired Thrombosis (CHAT) Consortium

Adoption of Prophylaxis in the United States in the Era of Extended Half-Life Factor Concentrates

Risk Factors for Hospital-Acquired Venous Thromboembolism in Children: Findings from the Children's Hospital-Acquired Thrombosis (CHAT) Registry

Thrombotic Events with NovoSeven ® RT in Approved Indications Are Rare (0.2%) and Associated with Older Age (>= 65 y), Cardiovascular Disease, and Concomitant Use of aPCCs

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds

Central Venous Catheters, a Major Culprit for Pediatric Venous Thrombosis: A Report from the Children's Hospital Acquired Thrombosis (CHAT) Project

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only